AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents.
Agonists of GPR40 (FFA1) have been proposed as a means to treat type 2 diabetes. Through lead optimization of a high throughput screening hit, we have identified a novel GPR40 agonist called AMG 837. The objective of these studies was to understand the preclinical pharmacological properties of AMG 8...
Guardado en:
Autores principales: | Daniel C-H Lin, Jane Zhang, Run Zhuang, Frank Li, Kathy Nguyen, Michael Chen, Thanhvien Tran, Edwin Lopez, Jenny Ying Lin Lu, Xiaoyan Nina Li, Liang Tang, George R Tonn, Gayathri Swaminath, Jeff D Reagan, Jin-Long Chen, Hui Tian, Yi-Jyun Lin, Jonathan B Houze, Jian Luo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/729ea24e76304c709713d2c9927fb903 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents.
por: Jian Luo, et al.
Publicado: (2012) -
Acta Nº837
por: Banco Central de Chile
Publicado: (2019) -
Improvement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus.
por: Zi-lin Li, et al.
Publicado: (2012) -
Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
por: Matthias Apweiler, et al.
Publicado: (2021) -
Orthodontists in forensic facial approximation (FFA): current inter-disciplinary perspective
por: Priyanka Kapoor, et al.
Publicado: (2021)